ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,023, issued on May 12, was assigned to NodThera Ltd. (Little Chesterford, Great Britain).
"Sulfonylurea derivatives and uses thereof" was invented by Mark G. Bock (Lexington, Mass.), David Harrison (Essex, Great Britain) and Jane E. Scanlon (Essex, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compounds of Formula (I)and to their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for inhibiting the maturation of cytokines of the IL-1 family by inhibiting inflammasomes and may be used in t...